Video Courtesy of YouTube
Diabetes has made its mark in the medical world as a disease that demands utmost attention from medical experts in health preservation. With the prevalence of diabetes continuing to grow each year the world over, intentional actions have had to be made through diabetology studies to ensure that populations are able to adequately deal with diabetes and if possible, avoid it altogether.
Diabetology as a clinical science has paved the way for great milestones to be taken as far as the diagnosis, treatment and follow up of diabetic patients is concerned. Diabetologists are able to carry out the lab tests that are required to monitor the progress of diabetic patients. This can be done separately for each patient, so that they can get adequate treatment that is unique to their condition and as a result, long term complications can be avoided.
Diabetes in the UK
In the UK, health experts agree that the number of people with diabetes has continued to grow significantly. Between 1996 and 2010, the number of people diagnosed with diabetes grew from 1.4 million to 2.6 million. Predictions indicate that by 2025, over 4 million people in the UK will suffer from diabetes. This is attributed to increase in obesity as well as the population distribution showing a growing number of aged individuals.
However, diabetology in the UK has seen a number of breakthroughs in the management of diabetes, the most significant having been the introduction of the 'capsulin' which is an oral insulin pill that was launched in December of 2007. Previously, diabetic patients had to have their insulin medication injected, which proved to be problematic for those who either had needle phobia or serious trouble injecting.
Diabetes in India
India has in the past suffered very little in comparison to most other countries as a result of diabetes. The low prevalence rate has been quite intriguing, given the sedentary lifestyles, faulty diet and high stress levels inherent in the Indian population, which are all definitive of populations that suffer from the disease. However, it seems that India is running out of luck, since experts predict that by 2030, 87 million people in India will suffer from diabetes.
India has not made as much progress in diabetology in comparison to the first world. Whereas diabetes in the UK is treated primarily by family doctors, the hospital system is the only option for most Indian diabetic patients to seek treatment. Efforts are underway to familiarize doctors and consultants with trials that are being carried out by private international diabetology experts. These clinical research experts also conduct training to courses to make information on diabetes available to medical practitioners as well as the population in general.
Diabetology studies are a necessary tool that will aid populations in first, second and third-world countries to adequately deal with diabetes. Prevention is indeed a less costly preference to cure, and equipping people with knowledge through diabetology studies will go a long way in making this a reality.